Ricki Louise Fairley - 27 Mar 2023 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role: Director
Signature: /s/ Beth Hecht as Attorney-in-Fact
Issuer symbol: XERS
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 29 Mar 2023, 16:23:08 UTC
Next filing: 05 Jun 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney